Retrospective analyses have indicated that bilateral risk reduction mastectomy (BRRM) decreases breast cancer risk by at least 90 % in BRCA1 and BRCA2 mutation carries [10, 14]. The gene discussed is BRCA2; the disease is breast cancer.